Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Dover

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Drugs in Dermatology : JDD|November 7, 2022
#Laser Surgery: How Lasers are Portrayed on InstagramJessica Labadie, Supriya Immaneni, Jeffrey Dover
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|January 5, 2022
Surgical Dermatology and Private Equity: A Review of the Literature and DiscussionAlexander L Fogel, Sara Hogan, Jeffrey Dover
Skin Therapy Letter|July 13, 2023
DaxibotulinumtoxinA-lanm (Daxxify™): A Comprehensive OverviewNicole Salame, Ariel E Eber, Jeffrey Dover
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 8, 2026
Clinical Risk and Regulatory Oversight for Office-Based Cosmetic Procedures: A State-By-State AnalysisSara Hogan, Micah Brown, Jamon Thomas, et al.
Journal of the American Academy of Dermatology|October 27, 2012
Evaluating facial pores and skin texture after low-energy nonablative fractional 1440-nm laser treatmentsNazanin Saedi, Kathleen Petrell, Kenneth Arndt, et al.
Journal of Cosmetic Dermatology|September 18, 2021
The impact of COVD-19 on North American dermatology practicesMisha Zarbafian, Danny Guo, Jeffrey Dover, et al.
Aesthetic Surgery Journal|December 1, 2009
An analysis of safety data from five phase III clinical trials on the use of botulinum neurotoxin type A-ABO for the treatment of glabellar linesMark Rubin, Jeffrey Dover, Corey Maas, et al.
Archives of Dermatology|April 21, 2010
Blinded, randomized, quantitative grading comparison of minimally invasive, fractional radiofrequency and surgical face-lift to treat skin laxityMacrene Alexiades-Armenakas, David Rosenberg, Bradley Renton, et al.
Clinics in Dermatology|January 4, 2020
The malleability of beauty: perceptual adaptationMayra B C Maymone, Melissa Laughter, Jeffrey Dover, et al.
Journal of Drugs in Dermatology : JDD|June 23, 2009
The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatmentMark G Rubin, Jeffrey Dover, Richard G Glogau, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Drugs in Dermatology : JDD|November 7, 2022
#Laser Surgery: How Lasers are Portrayed on InstagramJessica Labadie, Supriya Immaneni, Jeffrey Dover
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|January 5, 2022
Surgical Dermatology and Private Equity: A Review of the Literature and DiscussionAlexander L Fogel, Sara Hogan, Jeffrey Dover
Skin Therapy Letter|July 13, 2023
DaxibotulinumtoxinA-lanm (Daxxify™): A Comprehensive OverviewNicole Salame, Ariel E Eber, Jeffrey Dover
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 8, 2026
Clinical Risk and Regulatory Oversight for Office-Based Cosmetic Procedures: A State-By-State AnalysisSara Hogan, Micah Brown, Jamon Thomas, et al.
Journal of the American Academy of Dermatology|October 27, 2012
Evaluating facial pores and skin texture after low-energy nonablative fractional 1440-nm laser treatmentsNazanin Saedi, Kathleen Petrell, Kenneth Arndt, et al.
Journal of Cosmetic Dermatology|September 18, 2021
The impact of COVD-19 on North American dermatology practicesMisha Zarbafian, Danny Guo, Jeffrey Dover, et al.
Aesthetic Surgery Journal|December 1, 2009
An analysis of safety data from five phase III clinical trials on the use of botulinum neurotoxin type A-ABO for the treatment of glabellar linesMark Rubin, Jeffrey Dover, Corey Maas, et al.
Archives of Dermatology|April 21, 2010
Blinded, randomized, quantitative grading comparison of minimally invasive, fractional radiofrequency and surgical face-lift to treat skin laxityMacrene Alexiades-Armenakas, David Rosenberg, Bradley Renton, et al.
Clinics in Dermatology|January 4, 2020
The malleability of beauty: perceptual adaptationMayra B C Maymone, Melissa Laughter, Jeffrey Dover, et al.
Journal of Drugs in Dermatology : JDD|June 23, 2009
The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatmentMark G Rubin, Jeffrey Dover, Richard G Glogau, et al.
Pageof 2